PharmaReports: Neurodegenerative & Neuroelectrophysiological Disorders
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
This channel focusses on the chronic neurodegenerative disorders. Reports investigating memory/cognitive decline are also listed here unless they are clearly unrelated to neurodegeneration. In addition, reports relating to acute neurodegeneration such as stroke and cerebral hemorrhage can be included here.
Showing results 1 - 50 of 88
- Critical Care Pharmaceutical Markets: A Strategic Analysis
- Neuroprotection - Drugs, Markets and Companies
- Nitric Oxide - Therapeutics, Markets and Companies
- Alzheimer disease - new drugs, markets and companies
- Drug Delivery in Central Nervous System Diseases - technologies,markets and companies
- Cell Therapy - Technologies, Markets and Companies
- Stem Cell Markets
- World Neurodegeneratives Disease Markets, 2005-2009
- Cannabinoid Market Forecasts & Analysis to 2012
- Pipeline Insight: Multiple Sclerosis - The oral revolution
- Early Toxicology: Markets and Approaches
- Multiple Sclerosis World Market Outlook to 2011
- Multiple Sclerosis - Disease-modifying efficacy and side effects guide treatment
- Alzheimer's Disease - Prescribing trends indicate that neurologists are not adhering to guidelines
- Pipeline Insight: Epilepsy - Pipeline drugs struggle to outshine their marketed predecessors
- Biotech Drug Delivery Systems - Key Company Intelligence & Market Outlook to 2012
- Parkinson's Disease and Restless Legs Syndrome - Reformulations set to drive near-term growth
- Parkinson's Disease - Review of Key Commercial Opportunities in the Symptomatic Treatment Market
- From Blockbuster to Nichebuster
- Monoclonal Antibodies 2007
- The Global Protein Therapeutics Market
- Biogenerics
- The Global Market and Future Outlook for Neurodegenerative Disorder Therapies 2007
- Therapeutic Vaccines
- Pipeline and Commercial Insight: Alzheimer’s Disease
- Neuroprotection in Stroke
- Renovis' NXY-059 - Safety profile and unmet need could drive approval
- Pipeline Insight: Acute Stroke - Considerable unmet need is balanced by substantial commercial risk
- Monoclonal Antibodies: Financial and strategic analysis of the mAb market
- Multiple Sclerosis - Continued growth makes the MS market a highly attractive investment
- Drug Discovery Tools for High-Content Analysis
- Personalized Medicine
- MULTIPLE SCLEROSIS - Therapy Area Pipeline Report
- ISCHEMIA - Therapy Area Pipeline Report
- STROKE - Therapy Area Pipeline Report
- ALZHEIMER DISEASE - Therapy Area Pipeline Report
- EPILEPSY - Therapy Area Pipeline Report
- PARKINSON DISEASE - Therapy Area Pipeline Report
- SEIZURES - Therapy Area Pipeline Report
- Pipeline and Commercial Insight: Parkinson's Disease
- Commercial Insight: Epilepsy
- Top Companies and Products in the RNA/DNA Therapy Products Market
- Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family
- Stakeholder Insight: Acute Stroke - TPA spurs infrastructure changes for the better
- Biosimilars Series: Strategic issues - Potential remains uncertain
- Translational Medicine in Biopharmaceutical Research and Development
- The CNS Market Outlook
- Multiple Sclerosis Market Analysis and Forecasts Report 2007-2022
- Pipeline Report - Neuronal alpha 7 nicotinic receptors: Candidates for the treatment of Alzheimers disease and Schizophrenia
- Pipeline Insight: Orphan Diseases in CNS - Huntington's Disease
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development